Published in
Wiley, European Journal of Heart Failure, 3(24), p. 406-420, 2022
DOI: 10.1002/ejhf.2414
Links
Tools
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)
Journal article published in 2022 by
Rudolf A. de Boer,
Stephane Heymans,
Johannes Backs,
Lucie Carrier,
Andrew J. S. Coats,
Stefanie Dimmeler,
Thomas Eschenhagen,
Gerasimos Filippatos,
Lior Gepstein,
Jean‐Sebastien Hulot,
Ralph Knöll,
Christian Kupatt,
Wolfgang A. Linke,
Christine E. Seidman,
C. Gabriele Tocchetti 
and other authors.
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 